1. 157P Phase I expansion of IMC-C103C, a MAGE-A4×CD3 ImmTAC bispecific protein, in ovarian carcinoma. (December 2022) Authors: Sweis, R.; Garralda, E.; Saavedra Santa Gadea, O.; Moore, K.N.; Davar, D.; Hamid, O.; Segal, N.H.; Evans, T.R.J.; Dar, M.; Yuan, Y.; Collins, L.; Kirk, P.B.; Karakuzu, O.; Lopez, J.S.; Melero, I. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 173P First-in-human study to evaluate the safety and clinical activity of FS222: A tetravalent bispecific antibody targeting PD-L1 and CD137, in patients with advanced solid tumors. (December 2022) Authors: De Velasco Oria, G.A.; Garralda, E.; Moreno Garcia, V.; Melero, I.; Victoria Ruiz, I.; Indacochea, A.; Cervantes, A.; Oberoi, A.; Jones, D.; Lakins, M.A.; Kayitalire, L. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 201P Phase II study of taminadenant (A2AR antagonist) + spartalizumab (anti PD-1 antibody) in patients with triple-negative breast cancer (TNBC). (December 2022) Authors: Jerusalem, G.; De Braud, F.G.M.; de Jonge, M.J.A.; Grell, P.; Gonçalves, A.; Tan, T.J.Y.; Greil, R.; Yap, T.A.; Lin, C-C.; Kornbluth, K.A.; Yang, X.; Vong, C.; Choudhury, S.; Mataraza, J.; Lee, L.H.; Otero, J.A.; Garralda, E. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 304 Vanucizumab reduces vessel permeability, perfusion and cellular density of tumor lesions in cancer patients as measured by DCE-MRI and DW-MRI. (September 2015) Authors: Nayak, T.; Massard, C.; Martinez Garcia, M.; Le Tourneau, C.; Boni, V.; Garralda, E.; Taus, A.; Albanell, J.; Lahr, A.; Krieter, O.; Hidalgo, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 335 Lurbinectedin (PM01183) in combination with paclitaxel (P) in patients (pts) with advanced solid tumors. (September 2015) Authors: Garralda, E.; Stathis, A.; Drilon, A.; Boni, V.; Hyman, D.; Calvo, E.; Griguolo, G.; Makker, V.; Doger, B.; Canziani, L.; Varghese, A.M.; Jimenez, E.; Luque, J.; Soto-Matos, A.; Szyldergemajn, S.; Sessa, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase 1/2, open-label, multicenter study to investigate the safety, pharmacokinetics, and efficacy of fadraciclib (CYC065), an oral CDK2/9 inhibitor, in subjects with advanced solid tumors and lymphoma. (October 2022) Authors: Piha-Paul, S.; Oh, D.Y.; Garralda, E.; Vieito, M.; Huang, J.; Kirschbaum, M.; Villanona-Calero, M. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dose escalation study of OMO-103, a first in class Pan-MYC-Inhibitor in patients (pts) with advanced solid tumors. (October 2022) Authors: Garralda, E.; Moreno, V.; Alonso, G.; Corral, E.; Hernandez-Guerrero, T.; Ramon, J.; Doger de Spéville, B.; Martinez, E.; Soucek, L.; Niewel, M.; Calvo, E. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Integrated palliative care in Europe: a qualitative systematic literature review of empirically-tested models in cancer and chronic disease. Issue 1 (December 2016) Authors: Siouta, Naouma; Van Beek, K.; van der Eerden, M.; Preston, N.; Hasselaar, J.; Hughes, S.; Garralda, E.; Centeno, C.; Csikos, A.; Groot, M.; Radbruch, L.; Payne, S.; Menten, J. Journal: BMC palliative care Issue: Volume 15:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Non-invasive biomarkers for response and survival prediction in patients with advanced solid tumours treated with immune checkpoint inhibitors (ICIs). (October 2022) Authors: Bernatowicz, K.; Vieito, M.; Berche, R.; Alonso, G.; Galvao, V.; Oberoi, H.K.; Braña, I.; Saavedra, O.; Muñoz-Couselo, E.; Grussu, F.; Belen, A.; Serna, G.; Rotxes, M.; Sanz, M.; Tabernero, J.; Toledo, R.; Nuciforo, P.; Garralda, E.; Perez-Lopez, R. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Representation of young adult(19–29 y) and elderly(>75 y) patients populations in an early drug development unit. (October 2022) Authors: Vieito Villar, M.; Rojas, K.; Roger, B.; Cristina, V.; Braña, I.; Lostes, J.; Alonso, G.; Galvao, V.; Saavedra, O.; Oberoi, H.; Oiiveira, M.; Gonzalez, M.; Oaknin, A.; Felip, E.; Elez, E.; Saura, C.; Carles, J.; Macarulla, T.; Garralda, E.; Tabernero, J. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗